Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial

Conclusions: Long-term MHT using percutaneous E2 gel and oral MP4 might attenuate cognitive decline in postmenopausal women with MCI.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research